Sign up to save your podcasts
Or
Share Fed Expected to Cut Rates
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Fed Expected to Cut Rates
Plus: Home-building slowed more than expected in August. And Eli Lilly says its investigational diabetes pill outperformed Novo Nordisk’s oral semaglutide in a clinical trial. Zoe Kuhlkin hosts.
View all episodes
By The Wall Street JournalPlus: Home-building slowed more than expected in August. And Eli Lilly says its investigational diabetes pill outperformed Novo Nordisk’s oral semaglutide in a clinical trial. Zoe Kuhlkin hosts.